Eva Medtec

Early Stage

Automated Lymphatic Therapy (ALT) Technology

Overview

Raised to Date: Raised: $118,614

Total Commitments ($USD)

Platform

StartEngine

Start Date

12/20/2022

Close Date

03/20/2023

Min. Goal

$9,999

Max. Goal

$1,235,000

Min. Investment

$299

Security Type

Equity - Common

Series

Seed

Funding Type

RegCF

Price Per Share

$1.49

Pre-Money Valuation

$11,030,000

Rolling Commitments ($USD)

Status

Active

Reporting Date

02/01/2023

Days Remaining

47

% of Min. Goal

1,186%

% of Max. Goal

10%

Likelihood of Max
unlikely
Avg. Daily Raise

$2,758

# of Investors

32

Momentum
warm.svg
Create a free account today to gain access to KingsCrowd analytics.
Location

Bloomington, Minnesota

Industry

Healthcare & Pharmaceuticals

Tech Sector

Medtech

Distribution Model

B2C

Margin

Low

Capital Intensity

High

Business Type

Growth

Eva Medtec, with a valuation of $11,030,000, is raising funds on Startengine. They make it possible for anyone to experience the benefits of automated lymphatic therapy with one simple, at-home system. Eva Medtec is targeting the $4B Pain Management Devices market. They have created and manufactured Neuroglide™, an over the counter, FDA-cleared medical device engineered to automate and emulate manual lymphatic drainage (MLD) therapy. Irene Waldridge founded Eva Medtec in 2016. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,234,999. The campaign proceeds will be used for company employment, inventory, working capital and clinical studies.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$68,149

$0

COGS

$75,458

$0

Tax

$0

$0

 

 

Net Income

$-885,098

$-794,843

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$20,486

$253,766

Accounts Receivable

$0

$0

Total Assets

$473,507

$603,758

Short-Term Debt

$147,154

$120,854

Long-Term Debt

$50,000

$31,214

Total Liabilities

$197,154

$152,068

Financials as of: 12/20/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$12.42 /month
billed annually
Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings (excluding risk)
Advanced company search ( with ratings)
Markets page filters and historical industry data
Get Edge Annual

Edge Pro

$41.58 /month
billed annually
Full site access including KingsCrowd's qualitative analyst reports.
Plan Includes:
Everything in Edge, plus
Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
Search and filter based on Analyst Reports
In-depth risk ratings for every raise
Get Edge Pro Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Eva Medtec on StartEngine 2022
$
Platform: StartEngine
Security Type: Equity - Common
Valuation: $11,030,000

Follow company

Follow Eva Medtec on StartEngine 2022
View on StartEngine